Focus on screening, not biomarkers
14 Dec 2017
Focus on screening, not biomarkers
Lenalidomide with rituximab for mantle cell lymphoma
Results of the AML 12 trial
Approaches to screening and early detection across Europe
ER positive breast cancer: Screening for clinical variables to predict late distance disease recurrence
Predicting late breast cancer recurrence with screening assays
Updated genomic screening tool for life-time breast cancer risk
The reality of pancreatic cancer
Personalised medicine for inherited breast cancer
Lung cancer screening across Europe
Field trials of essential TNM staging in Africa
Behavioural science in cancer control